Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

NCT05819892 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Dostarlimab
DRUG: Cisplatin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]